AP2005003220A0 - Novel polymorph of N-Methyl-N-(3-{3-[2-Thienylcarbonyl]-Pyrazol-[1,5-Alpha]-Pyrimidin-7-YI}Phenyl) Acetanide and compositions and methods related thereto. - Google Patents

Novel polymorph of N-Methyl-N-(3-{3-[2-Thienylcarbonyl]-Pyrazol-[1,5-Alpha]-Pyrimidin-7-YI}Phenyl) Acetanide and compositions and methods related thereto.

Info

Publication number
AP2005003220A0
AP2005003220A0 AP2005003220A AP2005003220A AP2005003220A0 AP 2005003220 A0 AP2005003220 A0 AP 2005003220A0 AP 2005003220 A AP2005003220 A AP 2005003220A AP 2005003220 A AP2005003220 A AP 2005003220A AP 2005003220 A0 AP2005003220 A0 AP 2005003220A0
Authority
AP
ARIPO
Prior art keywords
acetanide
thienylcarbonyl
pyrazol
pyrimidin
alpha
Prior art date
Application number
AP2005003220A
Other languages
English (en)
Inventor
Scott E Zook
Donald Hettinger
Henry R Dubois Iii
Original Assignee
Neurocrine Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurocrine Biosciences Inc filed Critical Neurocrine Biosciences Inc
Publication of AP2005003220A0 publication Critical patent/AP2005003220A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
AP2005003220A 2002-08-26 2003-08-26 Novel polymorph of N-Methyl-N-(3-{3-[2-Thienylcarbonyl]-Pyrazol-[1,5-Alpha]-Pyrimidin-7-YI}Phenyl) Acetanide and compositions and methods related thereto. AP2005003220A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40607202P 2002-08-26 2002-08-26
PCT/US2003/026870 WO2004018476A1 (en) 2002-08-26 2003-08-26 Novel polymorph of n-methyl-n-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-alpha]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto

Publications (1)

Publication Number Publication Date
AP2005003220A0 true AP2005003220A0 (en) 2005-03-31

Family

ID=31946959

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2005003220A AP2005003220A0 (en) 2002-08-26 2003-08-26 Novel polymorph of N-Methyl-N-(3-{3-[2-Thienylcarbonyl]-Pyrazol-[1,5-Alpha]-Pyrimidin-7-YI}Phenyl) Acetanide and compositions and methods related thereto.

Country Status (32)

Country Link
US (2) US6903106B2 (zh)
EP (1) EP1532152B1 (zh)
JP (2) JP4522859B2 (zh)
KR (1) KR101063033B1 (zh)
CN (1) CN1319974C (zh)
AP (1) AP2005003220A0 (zh)
AR (1) AR044191A1 (zh)
AT (1) ATE343581T1 (zh)
AU (1) AU2003268212B2 (zh)
BR (1) BR0313695A (zh)
CA (1) CA2493359C (zh)
DE (1) DE60309332T2 (zh)
DK (1) DK1532152T3 (zh)
EA (1) EA200500421A1 (zh)
EC (1) ECSP055703A (zh)
ES (1) ES2274260T3 (zh)
HK (1) HK1071373A1 (zh)
HR (1) HRP20050288A2 (zh)
IL (2) IL166621A0 (zh)
IS (1) IS7769A (zh)
MA (1) MA27519A1 (zh)
MX (1) MXPA05002251A (zh)
NO (1) NO20050615L (zh)
NZ (1) NZ538027A (zh)
OA (1) OA12917A (zh)
PE (1) PE20040979A1 (zh)
PL (1) PL374436A1 (zh)
PT (1) PT1532152E (zh)
TN (1) TNSN05058A1 (zh)
TW (1) TWI288135B (zh)
WO (1) WO2004018476A1 (zh)
ZA (1) ZA200501125B (zh)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1532152T3 (da) * 2002-08-26 2007-02-26 Neurocrine Biosciences Inc Ny polymorf af N-methyl-N- (3- (3- [2-thienylcarbonyl]-pyrazol- [1,5-alfa]-pyrimidin-7-yl) phenyl) acetamid og beslægtede sammensætninger og metoder
US7429596B2 (en) * 2003-06-20 2008-09-30 The Regents Of The University Of California 1H-pyrrolo [2,3-D] pyrimidine derivatives and methods of use thereof
EP1844047A1 (en) * 2004-10-18 2007-10-17 Neurocrine Biosciences, Inc. Hydrate of n-methyl-n-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-alpha]- pyramidin-7-yl}phenyl)acetamide and processes and methods related thereto
CN100528875C (zh) * 2005-02-18 2009-08-19 美德（江西）生物科技有限公司 无结晶型态的印地普隆及其制备方法
EP1918290A1 (en) * 2006-10-11 2008-05-07 Ferrer Internacional, S.A. Polymorph B of N-{2-Fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo[1,5-a] pyrimidin-7-yl]-phenyl}-N-methyl-acetamide
EP1956021A1 (en) * 2006-10-11 2008-08-13 Ferrer Internacional, S.A. Process for the manufacture of a crystalline pyrazolo[1,5-a]pyrimidine compound
CN101177427B (zh) * 2006-11-09 2011-07-20 中国人民解放军军事医学科学院放射与辐射医学研究所 一种用于催眠的化合物的多晶型α和溶剂化物,其制备方法及含该物质的组合物
CN102180879B (zh) * 2006-11-09 2013-05-01 中国人民解放军军事医学科学院放射与辐射医学研究所 一种催眠药的多晶型α的乙酸溶剂化物
CN102834987B (zh) 2010-03-25 2015-04-15 矢崎总业株式会社 接头连接器和用于识别接头连接器中的汇流条图案的方法
EP2377830B1 (de) * 2010-04-16 2016-04-13 Ivoclar Vivadent AG Lithiumsilikat-Glaskeramik und -Glas mit Übergangsmetalloxid
AU2012214085B2 (en) 2011-02-11 2015-07-09 Nicoventures Trading Limited Inhaler component
AT510837B1 (de) 2011-07-27 2012-07-15 Helmut Dr Buchberger Inhalatorkomponente
CN102174048B (zh) * 2011-03-08 2014-09-17 中国人民解放军军事医学科学院放射与辐射医学研究所 一种催眠药的新多晶型β
KR102309513B1 (ko) 2011-09-06 2021-10-05 니코벤처스 트레이딩 리미티드 가열식 흡연가능 재료
GB201207039D0 (en) 2012-04-23 2012-06-06 British American Tobacco Co Heating smokeable material
GB2533135B (en) 2014-12-11 2020-11-11 Nicoventures Holdings Ltd Aerosol provision systems
GB201511349D0 (en) 2015-06-29 2015-08-12 Nicoventures Holdings Ltd Electronic aerosol provision systems
US20170055584A1 (en) 2015-08-31 2017-03-02 British American Tobacco (Investments) Limited Article for use with apparatus for heating smokable material
US11924930B2 (en) 2015-08-31 2024-03-05 Nicoventures Trading Limited Article for use with apparatus for heating smokable material
CA3103090C (en) 2016-04-27 2023-03-28 Nicoventures Trading Limited Electronic aerosol provision system and vaporizer therefor

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6399621B1 (en) 1999-08-10 2002-06-04 American Cyanamid Company N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1, 5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
US6472528B1 (en) 1999-08-10 2002-10-29 Neurocrine Biosciences, Inc. Synthesis of substituted pyrazolopyrimidines
US6485746B1 (en) 2000-08-25 2002-11-26 Neurocrine Biosciences, Inc. Controlled-release sedative-hypnotic compositions and methods related thereto
BR0014459A (pt) * 1999-09-02 2002-07-16 Neurocrine Biosciences Inc Polìmeros de n-metil-n- (3-{3-[2-tienilcarbonil]-pirazol-[1,5-"alfa"]-pirimidin-7-il } fenil) acetamida e composições e métodos relacionados aos mesmos
US6384221B1 (en) * 1999-09-02 2002-05-07 Neurocrine Biosciences, Inc. Polymorphs of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
JP2001177971A (ja) * 1999-12-20 2001-06-29 Auto Network Gijutsu Kenkyusho:Kk 回転接続装置
DK1532152T3 (da) * 2002-08-26 2007-02-26 Neurocrine Biosciences Inc Ny polymorf af N-methyl-N- (3- (3- [2-thienylcarbonyl]-pyrazol- [1,5-alfa]-pyrimidin-7-yl) phenyl) acetamid og beslægtede sammensætninger og metoder

Also Published As

Publication number Publication date
EP1532152B1 (en) 2006-10-25
WO2004018476A1 (en) 2004-03-04
US20040116446A1 (en) 2004-06-17
CN1319974C (zh) 2007-06-06
HK1071373A1 (en) 2005-07-15
DE60309332D1 (de) 2006-12-07
ZA200501125B (en) 2006-07-26
US7459458B2 (en) 2008-12-02
PL374436A1 (en) 2005-10-17
NO20050615L (no) 2005-03-22
NZ538027A (en) 2007-08-31
CA2493359A1 (en) 2004-03-04
DE60309332T2 (de) 2007-05-24
ECSP055703A (es) 2005-05-30
PE20040979A1 (es) 2005-01-07
PT1532152E (pt) 2007-02-28
EA200500421A1 (ru) 2005-08-25
KR101063033B1 (ko) 2011-09-07
TNSN05058A1 (en) 2007-05-14
MA27519A1 (fr) 2005-09-01
CA2493359C (en) 2009-10-27
JP2005538149A (ja) 2005-12-15
CN1678614A (zh) 2005-10-05
KR20050059082A (ko) 2005-06-17
TWI288135B (en) 2007-10-11
BR0313695A (pt) 2005-06-21
MXPA05002251A (es) 2005-06-08
ATE343581T1 (de) 2006-11-15
OA12917A (en) 2006-10-13
TW200406404A (en) 2004-05-01
ES2274260T3 (es) 2007-05-16
JP2010070561A (ja) 2010-04-02
HRP20050288A2 (en) 2006-10-31
DK1532152T3 (da) 2007-02-26
AR044191A1 (es) 2005-09-07
IL166621A (en) 2012-02-29
AU2003268212B2 (en) 2008-08-14
IL166621A0 (en) 2006-01-15
US6903106B2 (en) 2005-06-07
EP1532152A1 (en) 2005-05-25
US20050153988A1 (en) 2005-07-14
IS7769A (is) 2005-03-23
JP4522859B2 (ja) 2010-08-11
AU2003268212A1 (en) 2004-03-11

Similar Documents

Publication Publication Date Title
AP2005003220A0 (en) Novel polymorph of N-Methyl-N-(3-{3-[2-Thienylcarbonyl]-Pyrazol-[1,5-Alpha]-Pyrimidin-7-YI}Phenyl) Acetanide and compositions and methods related thereto.
AP2201A (en) Sustained-release tablet composition of pramipexole.
EP1556357A4 (en) COMPOUNDS, COMPOSITIONS AND METHODS
EP1542699A4 (en) COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF
EP1692112A4 (en) COMPOUNDS, COMPOSITIONS, AND METHODS
WO2004069152A3 (en) Δ4,5 glycuronidase and uses thereof
EP1756040A4 (en) PHENYL CARBOXAMIDE COMPOUNDS FOR USE AS BETA SECRETASE INHIBITORS IN THE TREATMENT OF ALZHEIMER'S DISEASE
EP1511734A4 (en) COMPOUNDS, COMPOSITIONS, AND METHODS
WO2004082623A3 (en) Substituted piperidine compounds
HK1096549A1 (en) Imidazopyridine-derivatives as inducible no-synthase inhibitors
ZA200700159B (en) Phenyl substituted [1.2]-oxazine-3,5-dione and dihydropyrone derivatives
IS7187A (is) 3-asabísýkló (3.1.0) hexanafleiður sem ópíóíðviðtaka mótlyf
WO2004099197A3 (de) Substituierte oxyarene und deren verwendung zur bekämpfung von schädlingen
HK1083844A1 (en) N-[3-(3-substituted-pyrazolo[1,5-a] pyrimidin-7-yl) phenyl]-sulfonamides, and compositions, and methods related thereto
IS2473B (is) Samsetning sem inniheldur N-(3-metoxý-5-metýlpýrasín-2-ýl)-2-(4-(1,3,4-oxadíasól-2-ýl)fenýl)pýridín-3-súlfónamíð (ZD4054), eða lyfjafræðilega viðurkennt salt þess, og EGFR TKI, eða lyfjafræðilega viðurkennt salt þess
WO2004112704A3 (en) Substituted piperidine compounds and methods of their use
EP1651231A4 (en) CYCLOALKANES DIPHENYL-SUBSTITUTES, COMPOSITIONS CONTAINING THESE COMPOUNDS, AND METHODS OF USE
HK1077296A1 (en) 2,5-Disubstituted 3-mercaptopentanoic acid
AU2003282804A1 (en) 3-(3,5-disubstituted-4-hydroxyphenyl)propionamide derivatives as cathepsin b inhibitors
NO20050885L (no) Ny fremgangsmate for syntesen av 1,3-dihydro-2H-3-benzazepin-2-onforbindelser, og anvendelse i syntesen av ivabradin og addisjonssalter derav med en farmasoytisk akseptabel syre
PL1786759T3 (pl) Nowe pochodne 3,5-seko-4-norcholestanowe i ich zastosowanie
EP1558083A4 (en) COMPOUNDS, COMPOSITIONS AND METHODS
WO2004067703A3 (en) 5ht7 antagonists and inverse agonists
EP1594849A4 (en) COMPOUNDS, COMPOSITIONS, AND METHODS
WO2006122012A3 (en) Polymorphic forms of (s)- tetrahydrofuran-3-yl-3-(3-(3-methoxy-4-(oxazol-5-yl) phenyl) ureido) benzylcarbamate